Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts
- 1 June 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (12) , 92-98
- https://doi.org/10.1016/s0002-9149(99)00269-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Amlodipine Releases Nitric Oxide From Canine Coronary MicrovesselsCirculation, 1998
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidaseFEBS Letters, 1995
- Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.Heart, 1995
- Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.Journal of Clinical Investigation, 1995
- Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.Circulation, 1993
- Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.Hypertension, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.Circulation, 1990
- The Mechanochemistry of Cardiac MuscleThe Journal of general physiology, 1967